HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling Li Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

1/2022Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma.
1/2022Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study.
6/2021Ibrutinib combined with venetoclax for the treatment of relapsed/refractory diffuse large B cell lymphoma.
1/2021Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
12/2020Research on the midterm efficacy and prognosis of patients with diffuse large B-cell lymphoma by different evaluation methods in interim PET/CT.
5/2020ENGINE: a Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1.
1/2020Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study.
1/2020PI3K/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma.
1/2019Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens.
12/2016Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling Li Research Topics

Disease

397Neoplasms (Cancer)
12/2022 - 01/2002
111Insulin Resistance
03/2022 - 04/2003
102Type 2 Diabetes Mellitus (MODY)
01/2022 - 09/2004
96Inflammation (Inflammations)
06/2022 - 11/2002
74Infections
09/2022 - 08/2002
60Breast Neoplasms (Breast Cancer)
08/2022 - 08/2003
60Neoplasm Metastasis (Metastasis)
08/2022 - 12/2003
52Nasopharyngeal Carcinoma
03/2022 - 01/2012
51Alzheimer Disease (Alzheimer's Disease)
11/2021 - 10/2002
43Body Weight (Weight, Body)
07/2021 - 06/2006
41Obesity
01/2022 - 04/2005
39Fibrosis (Cirrhosis)
02/2022 - 06/2002
37Hepatocellular Carcinoma (Hepatoma)
12/2022 - 01/2006
37Hypoxia (Hypoxemia)
09/2022 - 08/2002
31Melanoma (Melanoma, Malignant)
10/2022 - 06/2005
31Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 07/2003
31Atherosclerosis
01/2021 - 12/2003
27Lymphoma (Lymphomas)
06/2022 - 06/2013
24Hypertension (High Blood Pressure)
11/2022 - 04/2006
22Reperfusion Injury
09/2022 - 01/2002
22Leukemia
06/2022 - 02/2005
22Carcinogenesis
06/2022 - 08/2009
22Lung Neoplasms (Lung Cancer)
01/2021 - 12/2003
21Esophageal Squamous Cell Carcinoma
01/2022 - 11/2012
21Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2006
21Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 03/2013
21Heart Failure
01/2022 - 01/2009
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 12/2002
20Thrombosis (Thrombus)
04/2022 - 05/2004
20Myocardial Infarction
01/2022 - 03/2008
19Carcinoma (Carcinomatosis)
02/2021 - 02/2006
18Hyperglycemia
09/2022 - 10/2007
18Non-alcoholic Fatty Liver Disease
02/2022 - 07/2012
17Malaria
07/2022 - 07/2008
17Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 09/2010
17Necrosis
11/2021 - 04/2006
16Sepsis (Septicemia)
05/2022 - 01/2015
16Atherosclerotic Plaque (Atheroma)
04/2022 - 06/2009
16Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2022 - 10/2003
16Asthma (Bronchial Asthma)
12/2021 - 03/2007
16Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 07/2004
15Autism Spectrum Disorder
07/2022 - 01/2017
15Gestational Diabetes (Gestational Diabetes Mellitus)
05/2022 - 04/2016
15Glioma (Gliomas)
02/2022 - 12/2008
15Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 10/2005
14Stomach Neoplasms (Stomach Cancer)
10/2022 - 09/2003
14Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2009
14Colonic Neoplasms (Colon Cancer)
01/2022 - 11/2006
14Diabetes Mellitus
01/2022 - 08/2006
14Ischemia
01/2022 - 06/2002
13Liver Neoplasms (Liver Cancer)
12/2022 - 10/2013
13Prostatic Neoplasms (Prostate Cancer)
06/2022 - 11/2012
13Rupture
04/2022 - 05/2009

Drug/Important Bio-Agent (IBA)

189Proteins (Proteins, Gene)FDA Link
12/2022 - 01/2002
116Glucose (Dextrose)FDA LinkGeneric
08/2022 - 04/2003
96Pharmaceutical PreparationsIBA
06/2022 - 07/2005
87Biomarkers (Surrogate Marker)IBA
08/2022 - 02/2004
62Insulin (Novolin)FDA Link
01/2022 - 06/2003
50LipidsIBA
04/2022 - 10/2004
49CytokinesIBA
01/2022 - 10/2007
43Messenger RNA (mRNA)IBA
01/2022 - 06/2003
42Biological ProductsIBA
08/2022 - 12/2003
42MicroRNAs (MicroRNA)IBA
01/2022 - 08/2009
35Blood Glucose (Blood Sugar)IBA
06/2022 - 02/2005
34CholesterolIBA
01/2022 - 02/2003
33Cisplatin (Platino)FDA LinkGeneric
12/2022 - 01/2009
31Therapeutic UsesIBA
09/2022 - 02/2003
29RNA (Ribonucleic Acid)IBA
02/2022 - 12/2003
25DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2002
24Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021 - 02/2006
23EnzymesIBA
06/2022 - 07/2002
22Transcription Factors (Transcription Factor)IBA
06/2022 - 08/2005
22Long Noncoding RNAIBA
05/2022 - 04/2013
22Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2009
21Anti-Bacterial Agents (Antibiotics)IBA
05/2022 - 12/2003
21AntioxidantsIBA
01/2022 - 07/2002
18AntigensIBA
08/2022 - 10/2005
18AdiponectinIBA
01/2022 - 01/2006
18Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 08/2003
18Peptides (Polypeptides)IBA
01/2022 - 04/2003
18Metformin (Glucophage)FDA LinkGeneric
06/2021 - 07/2005
17Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 12/2003
16CollagenIBA
02/2022 - 06/2002
16Apolipoproteins E (ApoE)IBA
11/2021 - 12/2007
15VaccinesIBA
08/2022 - 07/2008
15Reactive Oxygen Species (Oxygen Radicals)IBA
09/2021 - 05/2007
15LipopolysaccharidesIBA
01/2021 - 07/2005
14artemisinin (artemisinine)IBA
07/2022 - 01/2016
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 01/2002
14Phosphotransferases (Kinase)IBA
05/2022 - 04/2005
14Paclitaxel (Taxol)FDA LinkGeneric
02/2022 - 07/2011
13CateninsIBA
06/2022 - 11/2014

Therapy/Procedure

201Therapeutics
12/2022 - 02/2002
90Drug Therapy (Chemotherapy)
06/2022 - 02/2002
56Radiotherapy
01/2022 - 02/2002
27Chemoradiotherapy
01/2022 - 07/2011
22Immunotherapy
10/2022 - 02/2013
22Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
05/2021 - 10/2014
18Aftercare (After-Treatment)
01/2021 - 12/2003
16Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 02/2003